May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Use of the Baerveldt Glaucoma Implant in Managing Refractory Childhood Glaucomas
S. Gedde; D. Budenz; J. Brandt; D. Kira; E. Larson
Author Affiliations & Notes
  • S. Gedde
    Ophthalmology, Bascom Palmer Eye Institute, Miami, FL
  • D. Budenz
    Ophthalmology, Bascom Palmer Eye Institute, Miami, FL
  • J. Brandt
    Ophthalmology, University of California, Davis, Sacramento, CA
  • D. Kira
    Ophthalmology, University of California, Davis, Sacramento, CA
  • E. Larson
    Ophthalmology, Bascom Palmer Eye Institute, Miami, FL
  • Footnotes
    Commercial Relationships  S. Gedde, None; D. Budenz, None; J. Brandt, None; D. Kira, None; E. Larson, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 979. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Use of the Baerveldt Glaucoma Implant in Managing Refractory Childhood Glaucomas
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      S. Gedde, D. Budenz, J. Brandt, D. Kira, E. Larson; Use of the Baerveldt Glaucoma Implant in Managing Refractory Childhood Glaucomas . Invest. Ophthalmol. Vis. Sci. 2004;45(13):979.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Abstract: : Purpose: To evaluate the effectiveness and safety of the Baervedlt glaucoma implant (BGI) in managing childhood glaucomas. Methods: The medical records of children under the age of 18 years who underwent BGI surgery between March 1991 and November 2000 were retrospectively reviewed. Results: 62 eyes of 62 patients were identified. The mean patient age (+SD) at time of BGI surgery was 6.5+5.6 years. With an average follow–up of 30.7+26.5 months, intraocular pressure was reduced from a mean of 35.0+8.7 mm Hg preoperatively to 14.0+3.9 mm Hg at last follow–up visit (p<0.001). Kaplan Meier survival analysis showed a cumulative success of 78% at 12 months, 65% at 24 months, and 58% in months 28 through 106. There was no difference between primary (21) and secondary glaucoma (41) patients in terms of length of follow–up, final intraocular pressure, number of medications, or cumulative success (p=0.16) Conclusions: BGI surgery appears to be a safe and effective treatment for refractory glaucoma in children.

Keywords: clinical (human) or epidemiologic studies: outcomes/complications • intraocular pressure 
© 2004, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2025 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept